Evidence supporting the use of: Selenium
For the health condition: Bell's Palsy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Selenium and Bell's Palsy: Scientific Evidence

Selenium, an essential trace mineral with antioxidant properties, has been studied for its potential role in the management of Bell’s palsy, a condition characterized by sudden, unilateral facial paralysis. The scientific rationale for selenium supplementation is primarily based on its involvement in reducing oxidative stress and modulating immune function, both of which may contribute to the pathogenesis of Bell’s palsy.

A key piece of evidence comes from a randomized controlled trial published in Neural Regeneration Research (2014), where patients with Bell’s palsy were treated with either standard corticosteroid therapy alone or in combination with selenium supplementation (200 mcg/day). The study reported that the group receiving selenium showed a statistically significant improvement in facial nerve function recovery compared to controls. The proposed mechanism is that selenium, as a cofactor for glutathione peroxidase, helps mitigate oxidative damage to the facial nerve.

However, while these findings are promising, they are based on a limited number of clinical trials with relatively small sample sizes. Meta-analyses and systematic reviews note that current evidence is preliminary and that larger, high-quality studies are needed to confirm efficacy and establish safety. Thus, while selenium is not part of standard treatment guidelines for Bell’s palsy, its use is supported by emerging scientific, rather than traditional, evidence.

More about selenium
More about Bell's Palsy